Skip to main content
. 2023 Dec 11;14:1304970. doi: 10.3389/fendo.2023.1304970

Table 1.

Basic characteristics of the study groups.

Parameter Obese (15-19 years) Obese (10-15 years) p Lean (15-19 years) p
Baseline data
Age (years) 16.59 ± 0.93 (144) 12.71 ± 1.37 (213) <0.001 16.53 ± 0.98 (20) 0.765
Sex (% of females) 47.2 (144) 47.4 (213) 1,000 55.0 (20) 0.634
Weight (kg) 102.82 ± 21.63 (144) 83.68 ± 19.64 (213) <0.001 66.3 ± 13.07 (20) <0.001
Height (cm) 173.14 ± 9.5 (144) 162.7 ± 10.68 (213) <0.001 171.72 ± 10.49 (20) 0.54
Height SDS 0.07 ± 1.08 (144) 0.69 ± 1.19 (213) <0.001 0.01 ± 1.24 (20) 0.816
BMI (kg/m2) 34.19 ± 6.19 (144) 31.34 ± 5.31 (213) <0.001 22.31 ± 2.69 (20) <0.001
BMI SDS 4.94 ± 2.3 (144) 4.21 ± 1.76 (213) 0.001 0.54 ± 0.98 (20) <0.001
TSH (mU/l)* 2.46; 1.68-3.42 (142) 2.86; 2.16-3.93 (211) 0.034 2.18; 1.63-2.55 (20) 0.117
FT4 (pmol/l) 15.07 ± 2.5 (144) 15.46 ± 2.56 (213) 0.157 16.08 ± 2.27 (20) 0.090
FT3 (pmol/l) 6.18 ± 1.11 (68) 6.78 ± 0.97 (116) <0.001 6.54 ± 1.13 (9) 0.362
Fasting serum glucose (mmol/l)* 4.80; 4.5-5.1 (128) 5.00; 4.7-5.2 (175) 0.123 5.05; 4.7-5.2 (14) 0.590
Urea (mmol/l) 3.85 ± 0.93 (111) 3.92 ± 0.87 (164) 0.511 4.02 ± 1.09 (9) 0.595
Creatinine (mmol/l) 63.63 ± 10.8 (137) 52.79 ± 9.8 (193) <0.001 61.24 ± 10.98 (17) 0.391
Uric acid (μmol/l) 381.07 ± 89.09 (134) 353.34 ± 80.12 (186) 0.004 276.29 ± 79.77 (14) <0.001
Total serum proteins (g/l) 72.92 ± 4.93 (43) 73.21 ± 4.14 (76) 0.733 73.4 ± 3.32 (4) 0.851
AST (μkat/l)* 0.4; 0.33-0.49 (132) 0.4; 0.33-0.47 (184) 0.976 0.34; 0.31-0.37 (16) 0.067
ALT (μkat/l)* 0.45; 0.31-0.71 (135) 0.38; 0.28-0.55 (194) 0.144 0.25; 0.2-0.385 (17) 0.073
GGT (μkat/l)* 0.325; 0.26-0.49 (56) 0.25; 0.19-0.31 (101) 0.006 0.17; 0.17-0.17 (1) 0.334
ALP (μkat/l)* 1.57; 1.32-1.98 (80) 3.81; 2.59-4.75 (142) <0.001 1.59; 1.13-3.25 (9) 0.477
Total-cholesterol (mmol/l) 4.16 ± 0.92 (128) 4.11 ± 0.79 (184) 0.621 3.73 ± 0.57 (13) 0.105
HDL-cholesterol (mmol/l) 1.12 ± 0.25 (119) 1.13 ± 0.23 (169) 0.755 1.42 ± 0.25 (6) 0.006
LDL-cholesterol (mmol/l) 2.68 ± 0.73 (118) 2.62 ± 0.71 (169) 0.496 2.31 ± 0.43 (6) 0.228
Triglycerides (mmol/l) 1.31 ± 0.59 (128) 1.38 ± 0.66 (186) 0.307 0.83 ± 0.45 (12) 0.006
Insulin (mU/l) 30.62 ± 25.41 (81) 31.55 ± 32.66 (126) 0.828 13.85 ± 1.48 (2) 0.356
High Sugar score 5.41 ± 1.16 (12) 5.39 ± 1.45 (14) 0.97 6.09 ± 1.01 (12) 0.142
High Complex Carbohydrate score 5.68 ± 0.96 (12) 5.67 ± 1.25 (14) 0.985 5.97 ± 1.07 (12) 0.491
High Protein score 5.41 ± 1.6 (12) 5.1 ± 1.41 (14) 0.605 5.5 ± 0.97 (12) 0.873
High Fat score 5.46 ± 1.01 (12) 5.52 ± 1.35 (14) 0.889 5.7 ± 0.76 (12) 0.511
Low Fiber score 5.67 ± 1.43 (9) 5.28 ± 1.61 (9) 0.592 6.05 ± 0.9 (8) 0.535
Score for foods cotaining ≥1.5g of Saturated FA per 100g 5.46 ± 1.13 (9) 5.06 ± 1.44 (9) 0.515 6.11 ± 0.67 (8) 0.181
Score for foods cotaining ≥1.5g of Polysaturated FA per 100g 5.54 ± 1.07 (9) 5.06 ± 1.42 (9) 0.434 6.2 ± 0.68 (8) 0.16
Score for foods cotaining ≥1.5g of Monosaturated FA per 100g 5.54 ± 1.06 (9) 5.13 ± 1.38 (9) 0.493 6.03 ± 0.74 (8) 0.287
Follow-up data
BMI (kg/m2) 34.09 ± 6.57 (144) 31.17 ± 5.35 (213) <0.001 22.43 ± 2.69 (20) <0.001
BMI SDS 4.89 ± 2.44 (144) 4.08 ± 1.8 (213) 0.001 0.58 ± 0.98 (20) <0.001
Duration of the follow-up (months) 5.40 ± 1.92 (144) 5.76 ± 1.80 (213) 0.096 6.60 ± 1.92 (20) 0.007
BMI change -0.1 ± 2.23 (144) -0.17 ± 2.24 (213) 0.773 0.12 ± 0.84 (20) 0.407
BMI-SDS change -0.05 ± 0.83 (144) -0.13 ± 0.78 (213) 0.334 0.04 ± 0.31 (20) 0.362
BMI-SDS change per year -0.18 ± 2.02 (144) -0.29 ± 1.79 (213) 0.578 0.06 ± 0.49 (20) 0.237

*Non-normally distributed data (TSH, fasting serum glucose, AST, ALT, GGT and ALP) are presented as the median and interquartile range, and were log transformed prior t-test. TSH, Thyroid-stimulating hormone; FT4, free thyroxine; FT3, free triiodothyronine; BMI, body mass index; SDS, standard deviation score; AST, aspartate aminotransferase; ALT, alanine aminotransferase; GGT, gamma-glutamyl transferase; ALP, alkaline phosphatase; FA, fatty acids. Value in parentheses (number of participants). P value was calculated in t-test for the difference between populations of adolescents with obesity and 1. children with obesity and 2. non-obese adolescents. All significant values (p<0.05) are in bold.